CN110283780A - 牛活体超排采卵方法和所用的制剂 - Google Patents
牛活体超排采卵方法和所用的制剂 Download PDFInfo
- Publication number
- CN110283780A CN110283780A CN201910651646.9A CN201910651646A CN110283780A CN 110283780 A CN110283780 A CN 110283780A CN 201910651646 A CN201910651646 A CN 201910651646A CN 110283780 A CN110283780 A CN 110283780A
- Authority
- CN
- China
- Prior art keywords
- ovum
- fsh
- preparation
- follicle
- ovary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000002322 Egg Proteins Human genes 0.000 title claims abstract description 129
- 108010000912 Egg Proteins Proteins 0.000 title claims abstract description 129
- 210000004681 ovum Anatomy 0.000 title claims abstract description 129
- 238000002360 preparation method Methods 0.000 title claims abstract description 68
- 238000000034 method Methods 0.000 title claims abstract description 62
- 238000005065 mining Methods 0.000 title abstract description 12
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 claims abstract description 87
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 claims abstract description 87
- 229940028334 follicle stimulating hormone Drugs 0.000 claims abstract description 87
- 210000000130 stem cell Anatomy 0.000 claims abstract description 47
- 210000000287 oocyte Anatomy 0.000 claims abstract description 20
- 238000001514 detection method Methods 0.000 claims abstract description 10
- 239000007864 aqueous solution Substances 0.000 claims abstract description 7
- 210000002394 ovarian follicle Anatomy 0.000 claims description 45
- 210000001672 ovary Anatomy 0.000 claims description 38
- 239000007788 liquid Substances 0.000 claims description 35
- 241000283690 Bos taurus Species 0.000 claims description 29
- 210000001161 mammalian embryo Anatomy 0.000 claims description 29
- CHZJRGNDJLJLAW-RIQJQHKOSA-N (8r,9s,13s,14s,16r,17r)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-16,17-diol Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1C[C@@H](O)[C@@]4(O)C#C)C)CC2=CC=3OC1CCCC1 CHZJRGNDJLJLAW-RIQJQHKOSA-N 0.000 claims description 27
- 229950007863 nilestriol Drugs 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 238000002347 injection Methods 0.000 claims description 22
- 239000007924 injection Substances 0.000 claims description 22
- 229920001983 poloxamer Polymers 0.000 claims description 18
- 241001465754 Metazoa Species 0.000 claims description 13
- 238000002604 ultrasonography Methods 0.000 claims description 13
- 235000019441 ethanol Nutrition 0.000 claims description 12
- 210000000664 rectum Anatomy 0.000 claims description 12
- 239000000523 sample Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 8
- 239000008227 sterile water for injection Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 206010002091 Anaesthesia Diseases 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 5
- 230000037005 anaesthesia Effects 0.000 claims description 5
- 235000015278 beef Nutrition 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 210000000805 cytoplasm Anatomy 0.000 claims description 5
- 235000013365 dairy product Nutrition 0.000 claims description 5
- 229960002897 heparin Drugs 0.000 claims description 5
- 229920000669 heparin Polymers 0.000 claims description 5
- 210000001215 vagina Anatomy 0.000 claims description 5
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims description 4
- 229930182555 Penicillin Natural products 0.000 claims description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 230000000903 blocking effect Effects 0.000 claims description 4
- 229940098773 bovine serum albumin Drugs 0.000 claims description 4
- 210000004246 corpus luteum Anatomy 0.000 claims description 4
- 238000011010 flushing procedure Methods 0.000 claims description 4
- 210000001733 follicular fluid Anatomy 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 150000002500 ions Chemical class 0.000 claims description 4
- 229960004194 lidocaine Drugs 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 210000005036 nerve Anatomy 0.000 claims description 4
- 229940049954 penicillin Drugs 0.000 claims description 4
- 239000011574 phosphorus Substances 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 239000013049 sediment Substances 0.000 claims description 4
- 239000012064 sodium phosphate buffer Substances 0.000 claims description 4
- 210000003905 vulva Anatomy 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 4
- 238000007796 conventional method Methods 0.000 abstract 1
- 235000013601 eggs Nutrition 0.000 description 43
- 244000309466 calf Species 0.000 description 30
- 229940088597 hormone Drugs 0.000 description 24
- 239000005556 hormone Substances 0.000 description 24
- 238000000338 in vitro Methods 0.000 description 24
- 238000012545 processing Methods 0.000 description 16
- 238000005516 engineering process Methods 0.000 description 14
- 230000004720 fertilization Effects 0.000 description 12
- 238000011161 development Methods 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 8
- 230000008217 follicular development Effects 0.000 description 7
- 230000006698 induction Effects 0.000 description 7
- 230000016087 ovulation Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 241000282553 Macaca Species 0.000 description 6
- 206010042573 Superovulation Diseases 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229920001993 poloxamer 188 Polymers 0.000 description 5
- 229940044519 poloxamer 188 Drugs 0.000 description 5
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- -1 hCG Proteins 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 241000283725 Bos Species 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000008182 oocyte development Effects 0.000 description 3
- 229960000502 poloxamer Drugs 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 238000003672 processing method Methods 0.000 description 3
- 241000282693 Cercopithecidae Species 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 210000002459 blastocyst Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000029849 luteinization Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 241000283730 Bos primigenius Species 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 241001504519 Papio ursinus Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 201000003511 ectopic pregnancy Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 241001515942 marmosets Species 0.000 description 1
- NCYVXEGFNDZQCU-UHFFFAOYSA-N nikethamide Chemical compound CCN(CC)C(=O)C1=CC=CN=C1 NCYVXEGFNDZQCU-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000000624 ovulatory effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000010010 raising Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 208000006685 tubal pregnancy Diseases 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0609—Oocytes, oogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910651646.9A CN110283780B (zh) | 2019-07-18 | 2019-07-18 | 牛活体超排采卵方法和所用的制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910651646.9A CN110283780B (zh) | 2019-07-18 | 2019-07-18 | 牛活体超排采卵方法和所用的制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110283780A true CN110283780A (zh) | 2019-09-27 |
CN110283780B CN110283780B (zh) | 2022-06-07 |
Family
ID=68023308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910651646.9A Active CN110283780B (zh) | 2019-07-18 | 2019-07-18 | 牛活体超排采卵方法和所用的制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110283780B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1559358A (zh) * | 2004-03-12 | 2005-01-05 | 中国科学院昆明动物研究所 | 肉、奶牛b超活体取卵方法 |
CN101962627A (zh) * | 2010-09-20 | 2011-02-02 | 北京奶牛中心 | 一种犊牛体外胚胎生产的方法 |
CN107714235A (zh) * | 2017-09-30 | 2018-02-23 | 新疆豪子畜牧业有限公司 | 一种利用母牛超排卵母细胞生产体外胚胎的方法 |
-
2019
- 2019-07-18 CN CN201910651646.9A patent/CN110283780B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1559358A (zh) * | 2004-03-12 | 2005-01-05 | 中国科学院昆明动物研究所 | 肉、奶牛b超活体取卵方法 |
CN101962627A (zh) * | 2010-09-20 | 2011-02-02 | 北京奶牛中心 | 一种犊牛体外胚胎生产的方法 |
CN107714235A (zh) * | 2017-09-30 | 2018-02-23 | 新疆豪子畜牧业有限公司 | 一种利用母牛超排卵母细胞生产体外胚胎的方法 |
Non-Patent Citations (3)
Title |
---|
KUZMINA, T. I.等: "Effects of prolactin in different culture systems on maturation of bovine oocytes and their capacity for subsequent development", 《ONTOGENEZ》 * |
周悟尘等: "《不孕不育300问》", 30 April 1994, 天津科学技术出版 * |
邵敬於等: "一种新型的尼尔雌醇与甲地孕酮周期疗法", 《中国新药杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN110283780B (zh) | 2022-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Galli et al. | Ovum pick up, intracytoplasmic sperm injection and somatic cell nuclear transfer in cattle, buffalo and horses: from the research laboratory to clinical practice | |
Luo et al. | Research advances in reproduction for dairy goats | |
Dowling | Problems of the transplantation of fertilized ova | |
Holtz | Recent developments in assisted reproduction in goats | |
De Roover et al. | Effects of ovum pick‐up frequency and FSH stimulation: a retrospective study on seven years of beef cattle in vitro embryo production | |
Callesen et al. | Factors affecting the developmental stage of embryos recovered on day 7 from superovulated dairy cattle | |
CN110251660A (zh) | 改进的牛活体采卵方法 | |
Konrad et al. | Ovum pick-up interval in buffalo (Bubalus bubalis) managed under wetland conditions in Argentina: Effect on follicular population, oocyte recovery, and in vitro embryo development | |
Yoshioka et al. | Production of piglets from in vitro-produced blastocysts by ultrasound-guided ovum pick-up from live donors | |
Hayden et al. | Synchronization of follicle wave emergence before ovarian superstimulation with FSH and ovum pick-up improves in vitro embryo production in pregnant heifers | |
Lamb et al. | In vitro fertilization (IVF) versus multiple ovulation embryo transfer (MOET): Making the decision to use one or both | |
CN110283780A (zh) | 牛活体超排采卵方法和所用的制剂 | |
Manjunatha et al. | Simplified superovulation protocols in dromedary camels (Camelus dromedarius) | |
Mansour et al. | Effect of the interval from GnRH administration after ovarian super-stimulation on the recovered oocytes, and effect of the transferred cloned blastocysts on the pregnancy rate and pregnancy loss in dromedary camel | |
CN107714235A (zh) | 一种利用母牛超排卵母细胞生产体外胚胎的方法 | |
Dickmann | Egg transfer in the mouse and rat | |
Falchi et al. | Intrafollicular oocyte transfer (IFOT): Potential feasibility in the ovine species | |
CN110438068B (zh) | 一种提高河流型水牛体外受精胚胎发育率的方法 | |
CN107460162A (zh) | 一种提高羔羊体外胚胎发育能力的方法 | |
CN105342723A (zh) | 一种提高奶水牛人工授精受胎率的方法 | |
CN107711611B (zh) | 一种台湾泥鳅低损、高效人工繁殖方法 | |
Demeterco et al. | The effects of intramuscular or intravenous injections of gonadotropin releasing hormone at fixed-time artificial insemination on pregnancy rates of Bos indicus beef cows | |
Lyuta et al. | Results of research on group formation donor cows and embryos transplantation. | |
dos Santos Marques | The impact of plasma concentrations of progesterone during superovulation on estrous behaviour, and ovarian and early embryonic development in Holstein heifers | |
Au et al. | Induced ovulation mimics the time-table of natural development in the stripe-faced dunnart, Sminthopsis macroura and results in the birth of fertile young |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190918 Address after: 300457 A building, Alexander center, 3 Haitong street, Tianjin Binhai New Area. Applicant after: Tianjin Bo Yu Li Husbandry Technology Co., Ltd. Address before: 300457 Tianjin Binhai New Area Development Zone Haitong Street No. 3 Alexander A building - Boya company Applicant before: Tianjin Bo Yu Li Husbandry Technology Co., Ltd. Applicant before: Tianjin Zhongke Boya biological Breeding Research Co Ltd |
|
TA01 | Transfer of patent application right | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 300457 building a, Alexandria, No.3 Haitong street, Binhai New Area Development Zone, Tianjin Boya company Applicant after: Tianjin Limu Biotechnology Co.,Ltd. Address before: 300457 A building, Alexander center, 3 Haitong street, Tianjin Binhai New Area. Applicant before: TIANJIN BOYU LIMU TECHNOLOGY CO.,LTD. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |